Medivation QA3 Loss Widens - Quick Facts

(RTTNews) - Medivation, Inc. (MDVN) reported a net loss for the third quarter of $13.3 million or $0.18 per share, wider than $4.5 million or $0.06 per share for the year-ago quarter.

Collaboration revenue for the latest third quarter seclined to $60.03 million from $64.80 million a year ago.

On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.26 per share on revenue of $60.13 million for the third quarter.

For the full year 2013, Medivation expects U.S. net sales of XTANDI, as reported by Astellas, to exceed its prior guidance of $345-365 million.